A booster dose is immunogenic and will be needed for older adults who have completed two doses vaccination with CoronaVac: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Minjie Li, Juan Yang, Lin Wang, Qianhui Wu, Zhiwei Wu, Wen Zheng, Lei Wang, Wanying Lu, Xiaowei Deng, Cheng Peng, Bihua Han, Yuliang Zhao, Hongjie Yu, Weidong Yin
doi: https://doi.org/10.1101/2021.08.03.21261544

Data Availability

All the data referred to in the manuscript will be provided with reasonable request after the trial is completed.

Back to top
Posted August 08, 2021.
Download PDF

Supplementary Material

Data/Code
Email
A booster dose is immunogenic and will be needed for older adults who have completed two doses vaccination with CoronaVac: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
Minjie Li, Juan Yang, Lin Wang, Qianhui Wu, Zhiwei Wu, Wen Zheng, Lei Wang, Wanying Lu, Xiaowei Deng, Cheng Peng, Bihua Han, Yuliang Zhao, Hongjie Yu, Weidong Yin
medRxiv 2021.08.03.21261544; doi: https://doi.org/10.1101/2021.08.03.21261544
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area